Quantitative-Morphological and Cytological Analyses in Leukemia

Leukemia, a blood cancer originating in the bone marrow, presents as a heterogeneous disease with highly variable survival rates. Leukemia is classified into major types based on the rate of cancerous cell growth and cell lineage: chronic or acute and myeloid or lymphoid leukemia. Histological and cytological analysis of the peripheral blood and the bone marrow can classify these major leukemia categories. However, histological analyses of patient biopsies and cytological microscopic assessment of blood and bone marrow smears are insufficient to diagnose leukemia subtypes and to direct therapy. Hence, more expensive and time-consuming diagnostic tools routinely complement histological-cytological analysis during a patient’s diagnosis. To extract more accurate and detailed information from patient tissue samples, digital pathology is emerging as a powerful tool to enhance biopsy- and smear-based decisions. Furthermore, digital pathology methods integrated with advances in machine learning enable new diagnostic features from leukemia patients’ histological and cytological slides and optimize patient classification, thus providing a cheaper, more robust, and faster diagnostic tool than current standards. This review summarizes emerging approaches to automatically diagnose leukemia from morphological and cytological-histological analyses

Automated Detection of Acute Leukemia using K-mean Clustering Algorithm

Leukemia is a hematologic cancer which develops in blood tissue and triggers rapid production of immature and abnormal shaped white blood cells. Based on statistics it is found that the leukemia is one of the leading causes of death in men and women alike. Microscopic examination of blood sample or bone marrow smear is the most effective technique for diagnosis of leukemia. Pathologists analyze microscopic samples to make diagnostic assessments on the basis of characteristic cell features. Recently, computerized methods for cancer detection have been explored towards minimizing human intervention and providing accurate clinical information. This paper presents an algorithm for automated image based acute leukemia detection systems. The method implemented uses basic enhancement, morphology, filtering and segmenting technique to extract region of interest using k-means clustering algorithm. The proposed algorithm achieved an accuracy of 92.8% and is tested with Nearest Neighbor (KNN) and Naive Bayes Classifier on the data-set of 60 samples.Comment: Presented in ICCCCS 201

Rouleaux red blood cells splitting in microscopic thin blood smear images via local maxima, circles drawing, and mapping with original RBCs.

Splitting the rouleaux RBCs from single RBCs and its further subdivision is a challenging area in computer-assisted diagnosis of blood. This phenomenon is applied in complete blood count, anemia, leukemia, and malaria tests. Several automated techniques are reported in the state of art for this task but face either under or over splitting problems. The current research presents a novel approach to split Rouleaux red blood cells (chains of RBCs) precisely, which are frequently observed in the thin blood smear images. Accordingly, this research address the rouleaux splitting problem in a realistic, efficient and automated way by considering the distance transform and local maxima of the rouleaux RBCs. Rouleaux RBCs are splitted by taking their local maxima as the centres to draw circles by mid-point circle algorithm. The resulting circles are further mapped with single RBC in Rouleaux to preserve its original shape. The results of the proposed approach on standard data set are presented and analyzed statistically by achieving an average recall of 0.059, an average precision of 0.067 and F-measure 0.063 are achieved through ground truth with visual inspection

Vincristine-Induced Peripheral Neuropathy: Assessing Preventable Strategies in Paediatric Acute Lymphoblastic Leukaemia

Background: Acute Lymphoblastic Leukaemia is the most common cancer experienced by children with overall survival rates now exceeding 90%. However, most children will experience vincristine-induced peripheral neuropathy (VIPN) during treatment resulting in sensory-motor abnormalities. To date, there are no approved preventative therapeutics or mitigation strategies for VIPN. This body of work set out to: (1) establish a high-throughput and high-content assay with the capacity to identify neuroprotective compounds, (2) test the feasibility of repurposing olesoxime as a neuroprotectant, and (3) compare traditional statistical methods with machine learning models to identify patients at risk of VIPN. Methods: (1) In vitro neuronal cultures were exposed to vincristine to recapitulate the VIPN phenotype and olesoxime assessed as a positive control. The neurotoxicity assay was miniaturised in 384-well microplates with automation steps to reduce manual handling. (2) Olesoxime and vincristine were applied to proliferating malignant cell lines to ensure the efficacy of vincristine was maintained. (3) Machine learning algorithms were developed using data from a local retrospective cohort to predict VIPN. Results: (1) Neurite length was reduced in a dose-responsive manner with vincristine. Assay miniaturisation and automation steps helped facilitate a high-throughput workflow. An optimised multiplexed dye solution enabled image acquisition and neurite quantification. Further, olesoxime was found to protect neurites and deemed suitable as a positive control (2) Cell viability assays confirmed olesoxime did not interfere with vincristine efficacy in leukemia cells. (3) Machine learning algorithms showed equivalency to traditional univariate analysis. The observation of severe class imbalance meant that patients who were least susceptible to VIPN could be identified. Conclusions: This body of work demonstrates the successful development of a neurotoxicity assay suitable for neuroprotectant drug discovery. Olesoxime was found suitable as a positive control in the assay. Further, viability studies indicated that vincristine retains it efficacy with olesoxime, opening the possibility of its use as an adjunctive therapy. Finally, this work developed machine learning models with the capacity to identify patients with VIPN-free survival. The utility of this model may mean that it can be used to stratify patients prospectively in the clinic based on favourable clinical features

Hematological image analysis for acute lymphoblastic leukemia detection and classification

Microscopic analysis of peripheral blood smear is a critical step in detection of leukemia.However, this type of light microscopic assessment is time consuming, inherently subjective, and is governed by hematopathologists clinical acumen and experience. To circumvent such problems, an efficient computer aided methodology for quantitative analysis of peripheral blood samples is required to be developed. In this thesis, efforts are therefore made to devise methodologies for automated detection and subclassification of Acute Lymphoblastic Leukemia (ALL) using image processing and machine learning methods.Choice of appropriate segmentation scheme plays a vital role in the automated disease recognition process. Accordingly to segment the normal mature lymphocyte and malignant lymphoblast images into constituent morphological regions novel schemes have been proposed. In order to make the proposed schemes viable from a practical and real–time stand point, the segmentation problem is addressed in both supervised and unsupervised framework. These proposed methods are based on neural network,feature space clustering, and Markov random field modeling, where the segmentation problem is formulated as pixel classification, pixel clustering, and pixel labeling problem respectively. A comprehensive validation analysis is presented to evaluate the performance of four proposed lymphocyte image segmentation schemes against manual segmentation results provided by a panel of hematopathologists. It is observed that morphological components of normal and malignant lymphocytes differ significantly. To automatically recognize lymphoblasts and detect ALL in peripheral blood samples, an efficient methodology is proposed.Morphological, textural and color features are extracted from the segmented nucleus and cytoplasm regions of the lymphocyte images. An ensemble of classifiers represented as EOC3 comprising of three classifiers shows highest classification accuracy of 94.73% in comparison to individual members. The subclassification of ALL based on French–American–British (FAB) and World Health Organization (WHO) criteria is essential for prognosis and treatment planning. Accordingly two independent methodologies are proposed for automated classification of malignant lymphocyte (lymphoblast) images based on morphology and phenotype. These methods include lymphoblast image segmentation, nucleus and cytoplasm feature extraction, and efficient classification

Evaluation of PD-L1 expression in various formalin-fixed paraffin embedded tumour tissue samples using SP263, SP142 and QR1 antibody clones

Background & objectives: Cancer cells can avoid immune destruction through the inhibitory ligand PD-L1. PD-1 is a surface cell receptor, part of the immunoglobulin family. Its ligand PD-L1 is expressed by tumour cells and stromal tumour infltrating lymphocytes (TIL). Methods: Forty-four cancer cases were included in this study (24 triple-negative breast cancers (TNBC), 10 non-small cell lung cancer (NSCLC) and 10 malignant melanoma cases). Three clones of monoclonal primary antibodies were compared: QR1 (Quartett), SP 142 and SP263 (Ventana). For visualization, ultraView Universal DAB Detection Kit from Ventana was used on an automated platform for immunohistochemical staining Ventana BenchMark GX. Results: Comparing the sensitivity of two different clones on same tissue samples from TNBC, we found that the QR1 clone gave higher percentage of positive cells than clone SP142, but there was no statistically significant difference. Comparing the sensitivity of two different clones on same tissue samples from malignant melanoma, the SP263 clone gave higher percentage of positive cells than the QR1 clone, but again the difference was not statistically significant. Comparing the sensitivity of two different clones on same tissue samples from NSCLC, we found higher percentage of positive cells using the QR1 clone in comparison with the SP142 clone, but once again, the difference was not statistically significant. Conclusion: The three different antibody clones from two manufacturers Ventana and Quartett, gave comparable results with no statistically significant difference in staining intensity/ percentage of positive tumour and/or immune cells. Therefore, different PD-L1 clones from different manufacturers can potentially be used to evaluate the PD- L1 status in different tumour tissues. Due to the serious implications of the PD-L1 analysis in further treatment decisions for cancer patients, every antibody clone, staining protocol and evaluation process should be carefully and meticulously validated

Molecular Imaging

The present book gives an exceptional overview of molecular imaging. Practical approach represents the red thread through the whole book, covering at the same time detailed background information that goes very deep into molecular as well as cellular level. Ideas how molecular imaging will develop in the near future present a special delicacy. This should be of special interest as the contributors are members of leading research groups from all over the world

Metastatic Progression and Tumour Heterogeneity

Improved understanding of the cellular and molecular makeup of tumors in the last 30 years has unraveled a previously unexpected level of heterogeneity among tumor cells as well as within the tumor microenvironment. The concept of tumor heterogeneity underlines the realization that different tumors can display significant differences in their genomic content as well as in their overall behavior. Our capacity to better understand the heterogeneous make up of tumors has very important consequences on our ability to design efficient therapeutic strategies to improve patient survival. This book highlights several aspects of tumor heterogeneity in the context of metastatic development and summarize some of the challenges posed by heterogeneity for tumor diagnostics and therapeutic management of tumors

Smoking and Second Hand Smoking in Adolescents with Chronic Kidney Disease: A Report from the Chronic Kidney Disease in Children (CKiD) Cohort Study

The goal of this study was to determine the prevalence of smoking and second hand smoking [SHS] in adolescents with CKD and their relationship to baseline parameters at enrollment in the CKiD, observational cohort study of 600 children (aged 1-16 yrs) with Schwartz estimated GFR of 30-90 ml/min/1.73m2. 239 adolescents had self-report survey data on smoking and SHS exposure: 21 [9%] subjects had “ever” smoked a cigarette. Among them, 4 were current and 17 were former smokers. Hypertension was more prevalent in those that had “ever” smoked a cigarette (42%) compared to non-smokers (9%), p\u3c0.01. Among 218 non-smokers, 130 (59%) were male, 142 (65%) were Caucasian; 60 (28%) reported SHS exposure compared to 158 (72%) with no exposure. Non-smoker adolescents with SHS exposure were compared to those without SHS exposure. There was no racial, age, or gender differences between both groups. Baseline creatinine, diastolic hypertension, C reactive protein, lipid profile, GFR and hemoglobin were not statistically different. Significantly higher protein to creatinine ratio (0.90 vs. 0.53, p\u3c0.01) was observed in those exposed to SHS compared to those not exposed. Exposed adolescents were heavier than non-exposed adolescents (85th percentile vs. 55th percentile for BMI, p\u3c 0.01). Uncontrolled casual systolic hypertension was twice as prevalent among those exposed to SHS (16%) compared to those not exposed to SHS (7%), though the difference was not statistically significant (p= 0.07). Adjusted multivariate regression analysis [OR (95% CI)] showed that increased protein to creatinine ratio [1.34 (1.03, 1.75)] and higher BMI [1.14 (1.02, 1.29)] were independently associated with exposure to SHS among non-smoker adolescents. These results reveal that among adolescents with CKD, cigarette use is low and SHS is highly prevalent. The association of smoking with hypertension and SHS with increased proteinuria suggests a possible role of these factors in CKD progression and cardiovascular outcomes